KA CHAN: Open Payments
NPI 1043500895 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,498 in 32 payments from 9 companies in 2025. Trend: 2023 $1,112 · 2024 $1,754 · 2025 $1,498
Food & beverage: $1,493Education: $5
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $319 |
| Janssen Pharmaceuticals, Inc | 6 | $296 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $177 |
| Axsome Therapeutics, Inc. | 3 | $176 |
| Esperion Therapeutics, Inc. | 9 | $165 |
| Teva Pharmaceuticals USA, Inc. | 3 | $148 |
| ABBVIE INC. | 1 | $100 |
| Otsuka America Pharmaceutical, Inc. | 1 | $95 |
| Alkermes, Inc. | 1 | $22 |
Products named: COBENFY, INVEGA SUSTENNA, CAPLYTA, Auvelity, NEXLETOL, UZEDY, VRAYLAR, ABILIFY MAINTENA.
Industry payments across WA — which companies pay providers there.
